Abstract
The PvuII and XbaI polymorphisms of ESR1 gene have been reported in the Alzheimer's disease (AD) studies. However, whether these ESR1 genetic variants can contribute to the risk of AD remains controversial. Herein, we conducted a meta-analysis to clarify the association between ESR1 polymorphisms and the occurrence of AD. Articles were identified by systematic searches in PubMed, Google scholar and Wan Fang Med Online database. The combined odds ratios (OR) and 95% confidence intervals (CI) were calculated within different inherited models. Publication bias tests, subgroup analyses and sensitive analyses were also performed. Overall, the PvuII variant was negatively associated with AD in the Caucasian population (pp vs PP+Pp, OR 0.86, 95%CI (0.76, 0.96)). However, there was a poor association between XbaI polymorphism and AD in European populations. In particular, PvuII variant was found significantly associated with a decreased AD risk in South European samples (pp vs PP+Pp, OR 0.86, 95%CI (0.75, 0.98)). This meta-analysis indicated that regional European differences of ESR1 PvuII polymorphism in the association with the occurrence of AD, which need to be further identified, especially in South European countries.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
